Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2005
11/24/2005CA2564952A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/23/2005EP1598365A1 Protection of endogenous therapeutic peptides
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/23/2005EP1597299A2 Carbonate esters of polyethylene glycol activated by means of oxalate esters
11/23/2005EP1597276A1 Therapeutic molecules
11/23/2005EP1596885A2 Uses of anti-insulin-like growth factor i receptor antibodies
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005EP1328276B1 Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation
11/23/2005CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/22/2005US6967237 For use in stimulating growth hormone secretion
11/22/2005US6967204 Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors
11/22/2005US6967094 Peptide for use in treatment of cancer, parkinson's and metabolic disorders
11/22/2005US6967089 Delivery system for porcine somatotropin
11/22/2005US6967019 Production of pancreatic islet cells and delivery of insulin
11/17/2005WO2005108399A1 Imidazopyridine compound
11/17/2005WO2005108337A2 Compounds with activity at estrogen receptor
11/17/2005US20050256210 Compounds with activity at estrogen receptors
11/17/2005US20050256198 2-[(4-{3-[benzyl(hexyl)amino]-3-oxopropyl}phenoxy)methyl]benzoic acid;peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256110 Cyanopyrroles
11/17/2005US20050256051 Nuclear receptor-mediated introduction of a PNA into cell nuclei
11/17/2005US20050256048 Selective androgen receptor modulators and methods for their identification, design and use
11/17/2005US20050255167 Medicinal Agent for Preventing and Treating Endocrine System Disturbances
11/17/2005US20050255156 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
11/17/2005CA2566184A1 Imidazopyridine compound
11/17/2005CA2565250A1 Cysteamines for treating complications of hypercholesterolemia and diabetes
11/17/2005CA2565094A1 Compounds with activity at estrogen receptor
11/16/2005EP1595867A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
11/16/2005EP1594545A2 Pharmaceutical composition for transdermal or transmucosal administration
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363608B1 Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleep disturbances
11/16/2005EP1274459B1 Sustained release formulations comprising growth hormone
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/16/2005EP0904099B1 Pharmaceutical formulation containing human growth hormone, histidine and a non-ionic detergent
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1227245C Food product and producing method
11/16/2005CN1227232C Process for preparing non-steroid glucocorticoid receptor regulator
11/16/2005CN1226999C Solubilized pharmaceutical composition for parenteral administration
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964971 Oral administering; sustained release
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964955 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
11/15/2005CA2357833C Treatment of pulmonary hypertension using vasopressin antagonist
11/15/2005CA2343148C Quick release pharmaceutical compositions of drug substances
11/10/2005WO2005105823A1 Steroid derivatives
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105148A2 Liquid growth hormone formulation
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250793 Preventives/remedies for hot flash
11/10/2005US20050250719 Inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2559918A1 Liquid growth hormone formulation
11/09/2005EP1593678A1 Crystal of (23s)-1alpha-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1377585B1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
11/09/2005EP1368025B1 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1204321B1 Super-active porcine growth hormone releasing hormone analog
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694881A New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1226304C Methylene steroids as novel androgens
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962928 such as 6-methoxy-2-(4-methoxyphenyl)-1-[4-(2-piperidin-1-yl-ethyoxy)-phenyl]-1,2,3,4-tetrahydroquinoline
11/08/2005US6962925 useful for the treatment of the pathologies mediated by the enzyme or for agricultural uses as plant growth regulators or herbicides
11/08/2005US6962919 Gonadotropin-releasing hormone antagonizing activity; useful as prophylactic or therapeutic agent for sex hormone-dependent diseases
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005102998A1 Novel androgens
11/03/2005WO2005102372A1 Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245545 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005US20050244966 Insulin producing cells
11/03/2005US20050244812 Kits and methods for detection of apoptotic cells
11/03/2005US20050244524 Blood sugar regulating product from soybean seeds
11/03/2005CA2562571A1 Novel androgens
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591446A1 Thienopyrimidine compounds and use thereof
11/02/2005EP1591143A1 Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
11/02/2005EP1591121A1 Steroid hormone products comprising a stabilizing agent in non-crystalline form
11/02/2005EP1425007B1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1237902B1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 290